[go: up one dir, main page]

ECSP11011110A - Derivados de morfina-6-glucuronido, su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de morfina-6-glucuronido, su preparacion y su aplicacion en terapeutica

Info

Publication number
ECSP11011110A
ECSP11011110A EC2011011110A ECSP11011110A ECSP11011110A EC SP11011110 A ECSP11011110 A EC SP11011110A EC 2011011110 A EC2011011110 A EC 2011011110A EC SP11011110 A ECSP11011110 A EC SP11011110A EC SP11011110 A ECSP11011110 A EC SP11011110A
Authority
EC
Ecuador
Prior art keywords
alkyl
alkyloxy
halo
therapeutics
application
Prior art date
Application number
EC2011011110A
Other languages
English (en)
Inventor
Alain Dlubala
Isabelle Ripoche
Claire Trecant
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ECSP11011110A publication Critical patent/ECSP11011110A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a derivados de morfina-6-glucurónido de fórmula (I) siguiente en la que R1 es un grupo heteroaromático de 5 eslabones eventualmente sustituido con uno o varios sustituyentes elegidos entre átomos de halógeno y los grupos alquilo(C1-C4), halógeno, hidroxilo, haloalquilo(C1-C4), haloalquiloxi(C1-C4), alquiloxi(C1-C4), aril-alquilo(C1-C4) y arilo, estando dicho grupo arilo eventualmente sustituido con uno o varios grupos elegidos entre los grupos alquilo(C1-C4), haloalquilo(C1-C4), hidroxilo y alquiloxi(C1-C4), en forma de base o de sal de adición a un ácido así como en el estado de hidrato o de solvato. La presente invención tiene también por objeto su procedimiento de preparación y su aplicación en terapéutica.
EC2011011110A 2008-12-10 2011-06-06 Derivados de morfina-6-glucuronido, su preparacion y su aplicacion en terapeutica ECSP11011110A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806949A FR2939437B1 (fr) 2008-12-10 2008-12-10 Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ECSP11011110A true ECSP11011110A (es) 2011-07-29

Family

ID=41031604

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2011011110A ECSP11011110A (es) 2008-12-10 2011-06-06 Derivados de morfina-6-glucuronido, su preparacion y su aplicacion en terapeutica

Country Status (29)

Country Link
US (1) US8461122B2 (es)
EP (1) EP2376512B1 (es)
JP (1) JP5616356B2 (es)
KR (1) KR20110104486A (es)
CN (1) CN102317301B (es)
AR (1) AR074514A1 (es)
AU (1) AU2009326909B2 (es)
BR (1) BRPI0922733A2 (es)
CA (1) CA2746429A1 (es)
CL (1) CL2011001399A1 (es)
CR (1) CR20110306A (es)
EA (1) EA019053B1 (es)
EC (1) ECSP11011110A (es)
ES (1) ES2468990T3 (es)
FR (1) FR2939437B1 (es)
HN (1) HN2011001601A (es)
IL (1) IL213381A (es)
MA (1) MA32952B1 (es)
MX (1) MX2011006252A (es)
MY (1) MY152978A (es)
NI (1) NI201100115A (es)
NZ (1) NZ593344A (es)
PE (1) PE20120260A1 (es)
SG (1) SG172068A1 (es)
TN (1) TN2011000266A1 (es)
TW (1) TW201026312A (es)
UA (1) UA104302C2 (es)
WO (1) WO2010067010A2 (es)
ZA (1) ZA201104305B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103421063B (zh) * 2012-05-23 2016-04-06 宜昌人福药业有限责任公司 一种合成吗啡-6-β-D-葡萄糖醛酸苷的方法
CN111346104B (zh) * 2018-12-21 2022-06-10 宜昌人福药业有限责任公司 一种吗啡-6-葡萄糖醛酸苷透皮给药的药物组合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
WO1998046618A1 (en) * 1997-04-14 1998-10-22 Salford Ultrafine Chemicals And Research Ltd. Morphine derivatives
IL139773A0 (en) 1998-06-06 2002-02-10 Cenes Ltd Morphine-6-glucuronide synthesis
GB0218811D0 (en) * 2002-08-14 2002-09-18 Cenes Ltd Salts of morphine-6-glucuronide
FR2864082B1 (fr) * 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur
JP5266492B2 (ja) * 2004-05-28 2013-08-21 ヒューマン バイオモレキュラル リサーチ インスティテュート 代謝安定性鎮痛薬、疼痛薬物療法及び他の物質の合成
FR2907121B1 (fr) * 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques

Also Published As

Publication number Publication date
US8461122B2 (en) 2013-06-11
FR2939437B1 (fr) 2010-12-17
CN102317301A (zh) 2012-01-11
EA201170792A1 (ru) 2012-01-30
CL2011001399A1 (es) 2011-10-28
CR20110306A (es) 2011-09-21
MA32952B1 (fr) 2012-01-02
TW201026312A (en) 2010-07-16
WO2010067010A3 (fr) 2011-06-30
NI201100115A (es) 2011-12-14
SG172068A1 (en) 2011-07-28
MX2011006252A (es) 2011-11-04
CA2746429A1 (fr) 2010-06-17
US20110301107A1 (en) 2011-12-08
CN102317301B (zh) 2015-08-26
EP2376512B1 (fr) 2014-02-26
BRPI0922733A2 (pt) 2016-01-05
JP2012511553A (ja) 2012-05-24
TN2011000266A1 (fr) 2012-12-17
IL213381A (en) 2014-02-27
WO2010067010A2 (fr) 2010-06-17
EA019053B1 (ru) 2013-12-30
PE20120260A1 (es) 2012-04-13
KR20110104486A (ko) 2011-09-22
IL213381A0 (en) 2011-07-31
ES2468990T3 (es) 2014-06-17
NZ593344A (en) 2013-08-30
AR074514A1 (es) 2011-01-19
HN2011001601A (es) 2013-09-16
MY152978A (en) 2014-12-15
JP5616356B2 (ja) 2014-10-29
AU2009326909B2 (en) 2016-05-26
AU2009326909A1 (en) 2011-06-30
HK1163110A1 (en) 2012-09-07
UA104302C2 (ru) 2014-01-27
FR2939437A1 (fr) 2010-06-11
ZA201104305B (en) 2012-10-31
EP2376512A2 (fr) 2011-10-19

Similar Documents

Publication Publication Date Title
MX2018016267A (es) Metodo para producir derivado de piridona policiclica sustituida y cristal del mismo.
BR112019003830A2 (pt) aditivos de combustível de base de mannich substituída, composições e métodos
UA105786C2 (uk) Адитивні солі амінів, що містять гідроксильні і/або карбоксильні групи, з похідними амінонікотинової кислоти як інгібітори dhodh
AR111811A2 (es) Compuestos derivados de 1,2,4-oxadiazol y composiciones para el control de nematodos
NZ745013A (en) Process for preparing bile acid derivatives
CR10784A (es) Nuevos derivados de aminopirimidina como inhibidores de plki
ES2571483T3 (es) Producto intermedio para producir un éster de ácido sulfónico cíclico
CO6251235A2 (es) Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica
ES2653265T3 (es) Morfinanos sustituidos y el uso de éstos
MX382161B (es) Una composicion plastificante que comprende di (2-etilhexil) tereftalato.
BR112016006262A2 (pt) composto, composição, material de acabamento automotivo interior ou exterior, artigo agrícola, e, métodos para estabilização de um material orgânico e preparação de um composto
TW201129564A (en) Diphenylpyrazolopyridine derivatives, preparation thereof and therapeutic use thereof
BR112017004667A2 (pt) método para preparação de um composto, composto, uso de um composto, método para preparação de gêneros alimentícios, e, produto alimentar ou aditivo alimentar.
MX2010006787A (es) Análogos halogenados de agentes anti-fibroticos.
ES2721623T3 (es) Procedimiento novedoso para la preparación de ceftarolina fosamil
BR112013008675A2 (pt) métodos e composições para o tratamento de diabetes e dislipidemia
BR112015006370A2 (pt) meios e métodos para tratamento de tumores sólidos
BR112017013266A2 (pt) processo para preparação de um composto, composto, e, usos de um composto e de uma dispersão.
ECSP11011110A (es) Derivados de morfina-6-glucuronido, su preparacion y su aplicacion en terapeutica
AR078094A1 (es) Octasacaridos n-acilos activadores de los receptores de los fgf, su preparacion y su aplicacion en terapeutica
DOP2011000296A (es) Compuesto de pirazol
CO6390061A2 (es) Derivados de morfina-6-glucuronido, su preparación y su aplicación en terapeutica
BR112014018985A8 (pt) Método para preparar um composto
CY1116477T1 (el) Μεθοδος εnzυμatiκης συνθεσης toy (7s)-3,4-διμεθοξυδικυκλο[4.2.0] οκτα-1,3,5-τριενo-7-καρβοξυλικου οξεος ή εστερων αυτου και εφαρμογη στην συνθεση της ιβαμπραδινης και των αλατων αυτης
CO6190551A2 (es) Derivado de alquilsulfona